Active ingredientBetrixabanCat. No. P-B068-001CAS 330942-05-7Family · Pharmaceutical analytical standards
Betrixaban
An oral anticoagulant that directly blocks clotting factor Xa, approved in the United States in 2017 to prevent venous thrombosis in hospitalised adults. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was the first anticoagulant approved to protect patients admitted with an acute illness both in hospital and for several weeks after discharge, up to about 42 days of treatment.
Go to the active ingredient →Active ingredientBetrixabanCat. No. P-B068-001CAS 330942-05-7
Isotopically labelledBetrixaban-d4Cat. No. P-B068-002
ImpurityBetrixaban 2-Amino ImpurityCat. No. P-B068-004CAS 280773-17-3
ImpurityBetrixaban Desmethoxy ImpurityCat. No. P-B068-005CAS 1616693-59-4
ImpurityBetrixaban Impurity 1Cat. No. P-B068-006CAS 330942-04-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.